CONTI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.152
EU - Europa 278
AS - Asia 180
SA - Sud America 17
AF - Africa 5
OC - Oceania 3
Totale 1.635
Nazione #
US - Stati Uniti d'America 1.139
SE - Svezia 83
IT - Italia 78
SG - Singapore 73
CN - Cina 48
IN - India 48
FI - Finlandia 29
DE - Germania 27
UA - Ucraina 26
AR - Argentina 14
GB - Regno Unito 12
CA - Canada 8
BG - Bulgaria 5
IE - Irlanda 4
NL - Olanda 4
TG - Togo 4
TR - Turchia 4
BE - Belgio 3
AU - Australia 2
BZ - Belize 2
CL - Cile 2
ES - Italia 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
RU - Federazione Russa 2
CO - Colombia 1
EG - Egitto 1
FR - Francia 1
GP - Guadalupe 1
HK - Hong Kong 1
ID - Indonesia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
Totale 1.635
Città #
Fairfield 161
Chandler 114
Ashburn 94
Woodbridge 78
Houston 76
Wilmington 63
Seattle 61
Cambridge 59
Singapore 57
Ann Arbor 32
Santa Clara 32
Dearborn 31
Princeton 30
San Paolo di Civitate 28
Beijing 27
Plano 27
Rome 23
Lawrence 19
San Diego 15
Boston 14
Federal 10
Los Angeles 10
Millbury 10
Jacksonville 9
Fremont 7
Falkenstein 6
Mannheim 6
Norwalk 6
Southend 6
Toronto 6
Sofia 5
Andover 4
Boardman 4
Buenos Aires 4
Dublin 4
Lomé 4
San Jose 4
Bremen 3
Brussels 3
Buffalo 3
Falls Church 3
Florence 3
Genoa 3
Guangzhou 3
Hefei 3
Las Vegas 3
Milan 3
New York 3
Albuquerque 2
Ankara 2
Barcelona 2
Belize City 2
Chicago 2
Helsinki 2
Kilburn 2
Kunming 2
Lamezia Terme 2
Munich 2
Nanjing 2
Ottawa 2
Polignano a Mare 2
Provo 2
Pune 2
Redmond 2
Redwood City 2
Sydney 2
Velletri 2
Zhengzhou 2
Amsterdam 1
Belgrade 1
Bologna 1
Bühl 1
Cairo 1
Charlotte 1
Chongqing 1
Frankfurt am Main 1
Guidonia 1
Hastings 1
Hebei 1
Indiana 1
Istanbul 1
Jakarta 1
Jesi 1
Kaiserslautern 1
Kepala Batas 1
Leawood 1
Les Abymes 1
Quzhou 1
Sacramento 1
San Mateo 1
Seversk 1
Shenyang 1
Tel Aviv 1
Xian 1
Totale 1.245
Nome #
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency 119
The VH1-69-expressing marginal zone B cells expanded in HCV-associated mixed cryoglobulinemia display proliferative anergy irrespective of CD21low phenotype. 101
Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13 86
Anti-endothelial cell antibodies in rheumatic heart disease 83
Persistence of a Large Population of Exhausted Monoclonal B cells in Mixed Cryoglobuliemia After the Eradication of Hepatitis C Virus Infection 79
Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: The yin and yang of HCV-driven lymphoproliferation and autoimmunity 77
Regression of Systemic Lupus Erythematosus After Development of an Acquired Toll-like Receptor Signaling Defect and Antibody Deficiency 76
High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease. 76
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 74
Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication 72
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia 69
Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. 69
UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE - AN UNSOLVED PROBLEM: REVISION OF LITERATURE AND CASE STUDIES 68
Lithiasis of semicircular canals and parotid glands: unusual stones deposition in atazanavir-treated individuals. 66
Splenic marginal zone lymphoma in a HIV-1 infected patient: evidence favouring a pathogenetic role of HIV-1 itself in the lymphomagenesis 57
Interleukin-2 therapy in patients with HIV infection. 55
B-cell memory defect in a SLE induced a severe antibody, stable clinical remission and succesful renal transplantation 54
null 51
Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency 48
The CD21low B Cells Expanded in Common Variable Immunodeficiency do not Differentiate to Antibody Producing Cells After Stimulation of Toll-like Receptor 9 Because of a Reduced Proliferative Potential 45
STUDIO PROSPETTICO MONOCENTRICO PER LA VALUTAZIONE DELLO STATO DI SALUTE MEDIANTE ‘‘PATIENT ACCEPTABLE SYMPTOM STATE’’ (PASS) IN PAZIENTI AFFETTI DA LUPUS ERITEMATOSO SISTEMICO: CORRELAZIONE GLI INDICI DI ATTIVITÀ DI MALATTIA 45
Defective proliferative response of B-lymphocytes upon stimulation of TLR7 and TLR9 in common variable immune deficiency 38
COMMON VARIABLE IMMUNODEFICIENCY - NEW INSIGHT INTO THE PATHOGENESIS AND THE QUEST FOR A WORKABLE CLASSIFICATION 38
[Health care and infective aspects in patients affected by common variable immunodeficiency assisted in the Lazio Regional Authority Reference Centre for Primary Immunodeficiencies]. 30
Ig levels and B cell differenziative capacity predict the risk of acute infections in CVID 27
The Marginal Zone B Cells Clonally Expanded in Hepatitis C-Related Mixed Cryoglobulinemia Display the Functional and Molecular Signatures of Anergy Induced by Continual B Cell Receptor Signaling 23
Replicative senescence prevents the differentiation of B-cells to antibody producine cells in common variable immunodeficiency 23
Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies 14
Totale 1.663
Categoria #
all - tutte 5.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020264 0 0 0 0 0 57 56 48 49 31 13 10
2020/202198 11 14 3 9 4 10 5 14 5 12 9 2
2021/2022258 1 12 33 5 36 2 7 29 20 25 39 49
2022/2023374 54 79 19 47 39 47 4 19 45 1 10 10
2023/2024121 5 17 5 16 11 9 5 6 1 21 10 15
2024/2025131 7 25 14 19 39 27 0 0 0 0 0 0
Totale 1.663